215
Views
1
CrossRef citations to date
0
Altmetric
Review

Achalasia, from diagnosis to treatment

, , &
Pages 21-30 | Received 03 Aug 2022, Accepted 23 Dec 2022, Published online: 01 Jan 2023

References

  • Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–1852.
  • Savarino E, Bhatia S, Roman S, et al. Achalasia. Nat Rev Dis Primers. 2022;8(1):28.
  • van Hoeij FB, Ponds FA, Smout AJ, et al. Incidence and costs of achalasia in The Netherlands. Neurogastroenterol Motil. 2018 Feb;30(2):e13195.
  • Harvey PR, Thomas T, Chandan JS, et al. Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. Gut. 2019 May;68(5):790–795.
  • Gaber CE, Eluri S, Cotton CC, et al. Epidemiologic and economic burden of achalasia in the United States. Clin Gastroenterol Hepatol. 2022 Feb;20(2):342–352.e5.
  • Vaezi MF, Pandolfino JE, Yadlapati RH, et al. ACG Clinical guidelines: diagnosis and management of achalasia. Am. J. Gastroenterol. 2020;115:1393–1411. .
  • Oude Nijhuis RAB, Zaninotto G, Roman S, et al. European guidelines on achalasia: united European Gastroenterology and European Society of Neurogastroenterology and Motility recommendations. United European Gastroenterol J. 2020;8(1):13–33.
  • Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur. J. Gastroenterol. Hepatol. 2008;20(10):956–960.
  • De Giorgio R, Di Simone MP, Stanghellini V, et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol. 1999 Sep;94(9):2357–2362.
  • Wu XY, Liu ZQ, Wang Y, et al. The etiology of achalasia: an immune-dominant disease. J Dig Dis. 2021 Mar;22(3):126–135.
  • Lee BE, Kim GH, Shin N, et al. Histopathological analysis of esophageal mucosa in patients with achalasia. Gut Liver. 2021 Sep 15 15(5):713–722.
  • Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993 Mar;34(3):299–302.
  • Naik RD, Vaezi MF, Gershon AA, et al. Association of achalasia with active varicella zoster virus infection of the esophagus. Gastroenterology. 2021 Aug;161(2):719–721.e2.
  • Kebuchi Y, Kanda T, Ikeda H, et al. Identification of human herpes virus 1 encoded microRNAs in biopsy samples of lower esophageal sphincter muscle during peroral endoscopic myotomy for esophageal achalasia. Dig Endosc. 2020 Jan;32(1):136–142.
  • Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol. 2008 Jul;103(7):1598–1609.
  • Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014 Jan 4; 383(9911):83–93.
  • Verne GN, Sallustio JE, Eaker EY. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Digestive Dis Sci. 1997;42(2):307–313.
  • Wong RK, Maydonovitch CL, Metz SJ, et al. Significant DQw1 association in achalasia. Digestive Dis Sci. 1989;34(3):349–352.
  • Kilpatrick ZM, Milles SS. Achalasia in mother and daughter. Gastroenterology. 1972;62(5):1042–1046.
  • Monnig PJ. Familial achalasia in children. Ann Thorac Surg. 1990;49(6):1019–1022.
  • Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992 Dec;103(6):1732–1738.
  • Urbach DR, Tomlinson GA, Harnish JL, et al. A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol. 2005 Aug;100(8):1668–1676.
  • Patel DA, Sharda R, Hovis KL, et al. Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation. Dis Esophagus. 2017 May 1 30(5):1–23.
  • Kostic S, Andersson M, Hellström M, et al. Timed barium esophagogram in the assessment of patients with achalasia: reproducibility and observer variation. Dis Esophagus. 2005;18(2):96–103.
  • Blonski W, Kumar A, Feldman J, et al. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018 Feb;113(2):196–203.
  • Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol. 2013 Jan;108(1):49–55.
  • Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil. 2021 Jan;33(1):e14058.
  • Zhou MJ, Kamal A, Freedberg DE, et al. Type II achalasia increasing in prevalence. Dig Dis Sci. 2020.
  • Hong SJ, Bhargava V, Jiang Y, et al. A unique esophageal motor pattern that involves longitudinal muscles is responsible for emptying in achalasia esophagus. Gastroenterology. 2010;139(1):102–111.
  • Park S, Zifan A, Kumar D, et al. Genesis of esophageal pressurization and bolus flow patterns in patients with achalasia esophagus. Gastroenterology. 2018;155(2):327–336.
  • Kim TH, Patel N, Ledgerwood-Lee M, et al. Esophageal contractions in type 3 achalasia esophagus: simultaneous or peristaltic? Am J Physiol Gastrointest Liver Physiol. 2016;310(9):G689–695.
  • Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry. Gastroenterology. 2013 Nov;145(5):954–965.
  • Ang D, Misselwitz B, Hollenstein M, et al., Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study. Lancet Gastroenterol Hepatol. 2017;2(9):654–661. .
  • Woodland P, Gabieta-Sonmez S, Arguero J, et al. 200 mL rapid drink challenge during high-resolution manometry best predicts objective esophagogastric junction obstruction and correlates with symptom severity. J Neurogastroenterol Motil. 2018;24(3):410–414.
  • Sanagapalli S, McGuire J, Leong RW, et al. The clinical relevance of manometric esophagogastric junction outflow obstruction can be determined using rapid drink challenge and solid swallows. Am J Gastroenterol. 2021;116(2):280–288.
  • Savarino E, Di Pietro M, Bredenoord AJ, et al. Use of the functional lumen imaging probe in clinical esophagology. Am J Gastroenterol. 2020 Nov;115(11):1786–1796.
  • Carlson DA, Kahrilas PJ, Lin Z, et al. Evaluation of esophageal motility utilizing the functional lumen imaging probe. Am J Gastroenterol. 2016 Dec;111(12):1726–1735.
  • Carlson DA, Crowell MD, Kimmel JN, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1502–1506.
  • Carlson DA, Baumann AJ, Prescott JE, et al. Prediction of esophageal retention: a study comparing high-resolution manometry and functional luminal imaging probe panometry. Am J Gastroenterol. 2021 Oct 1 116(10):2032–2041.
  • Carlson DA, Lin Z, Kahrilas PJ, et al. The functional lumen imaging probe detects esophageal contractility not observed with manometry in patients with achalasia. Gastroenterology. 2015 Dec;149(7):1742–1751.
  • Carlson DA, Gyawali CP, Khan A, et al. Classifying esophageal motility by FLIP panometry: a study of 722 subjects with manometry. Am J Gastroenterol. 2021 Dec 1 116(12):2357–2366.
  • Dantas RO. Management of esophageal dysphagia in chagas disease. Dysphagia. 2021 Jun;36(3):517–522.
  • Vicentine FP, Herbella FA, Allaix ME, et al. High-resolution manometry classifications for idiopathic achalasia in patients with Chagas’ disease esophagopathy. J Gastrointest Surg. 2014 Feb;18(2):221–224. discussion 224-5.
  • Vicentine FP, Herbella FA, Allaix ME, et al. Comparison of idiopathic achalasia and Chagas’ disease esophagopathy at the light of high-resolution manometry. Dis Esophagus. 2014 Feb-Mar;27(2):128–133.
  • Babaei A, Shad S, Massey BT. Motility patterns following esophageal pharmacologic provocation with amyl nitrite or cholecystokinin during high-resolution manometry distinguish idiopathic vs opioid-induced type 3 achalasia. Clin Gastroenterol Hepatol. 2020;18(4):813–821.e1.
  • Ribolsi M, Ghisa M, Savarino E. Nonachalasic esophageal motor disorders, from diagnosis to therapy. Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):205–216.
  • Gelfond M, Rozen P, Keren S, et al. Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid. Gut. 1981 Apr;22(4):312–318.
  • Coccia G, Bortolotti M, Michetti P, et al. Return of esophageal peristalsis after nifedipine therapy in patients with idiopathic esophageal achalasia. Am J Gastroenterol. 1992 Dec;87(12):1705–1708.
  • Coccia G, Bortolotti M, Michetti P, et al. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia. Gut. 1991 Jun;32(6):604–606.
  • Bortolotti M, Mari C, Lopilato C, et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology. 2000 Feb;118(2):253–257.
  • Bassotti G, Annese V. Review article: pharmacological options in achalasia. Aliment Pharmacol Ther. 1999 Nov;13(11):1391–1396.
  • Annese V, Bassotti G, Coccia G, et al., A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000;46(5): 597–600. .
  • Patti MG, Feo CV, Arcerito M, et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Digestive Dis Sci. 1999;44(11):2270–2276.
  • Horgan S, Hudda K, Eubanks T, et al. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc. 1999;13(6):576–579.
  • Smith CD, Stival A, Howell DL, et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone. Ann Surg. 2006;243(5):579–584. discussion 584–586.
  • Kumar AR, Schnoll-Sussman FH, Katz PO. Botulinum toxin and pneumatic dilation in the treatment of achalasia. Tech. Gastrointest. Endosc. 2014;16(1):10–19.
  • Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44(2):231–239.
  • Pasricha PJ, Rai R, Ravich WJ, et al., Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110(5): 1410–1415. .
  • van Hoeij FB, Prins LI, Smout AJPM, et al. Efficacy and safety of pneumatic dilation in achalasia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2019 Jul;31(7):e13548.
  • Müller M, Keck C, Eckardt AJ, et al. Outcomes of pneumatic dilation in achalasia: extended follow-up of more than 25 years with a focus on manometric subtypes. J Gastroenterol Hepatol. 2018 May;33(5):1067–1074.
  • Pratap N, Kalapala R, Darisetty S, et al. Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation. J Neurogastroenterol Motil. 2011 Jan;17(1):48–53.
  • Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013 Apr;144(4):718–725.
  • Torresan F, Cortellini F, Azzaroli F, et al. Graded pneumatic dilation in subtype I and II achalasia: long-term experience in a single center. Ann Gastroenterol. 2022;35(1):28–33.
  • Boeckxstaens GE, Annese V, Bruley Des Varannes S, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011 May 12;364(19):1807–1816.
  • Moonen A, Annese V, Belmans A, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–739.
  • Ghoshal UC, Kumar S, Saraswat VA, et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol. 2004 Dec;99(12):2304–2310.
  • Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004 May;2(5):389–394.
  • Guardino JM, Vela MF, Connor JT, et al. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol. Nov-Dec. 2004;38(10):855–860.
  • Schnurre L, Murray FR, Schindler V, et al. Short-term outcome after singular hydraulic EsoFLIP dilation in patients with achalasia: a feasibility study. Neurogastroenterol Motil. 2020 Sep;32(9):e13864.
  • Mundre P, Black CJ, Mohammed N, et al. Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):30–38.
  • Ortega JA, Madureri V, Perez L. Endoscopic myotomy in the treatment of achalasia. Gastrointest Endosc. 1980 Feb;26(1):8–10.
  • Pasricha PJ, Hawari R, Ahmed I, et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy. 2007 Sep;39(9):761–764.
  • Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265–271.
  • Evensen H, Kristensen V, Larssen L, et al. Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review. Scand J Gastroenterol. 2019 Jan;54(1):1–7.
  • Inoue H, Sato H, Ikeda H, et al. Per-Oral Endoscopic Myotomy: a series of 500 patients. J Am Coll Surg. 2015 Aug;221(2):256–264.
  • Sudarshan M, Raja S, Adhikari S, et al. Peroral endoscopic myotomy provides effective palliation in type III achalasia. J Thorac Cardiovasc Surg. 2022 Feb;163(2):512–519.e1.
  • Talukdar R, Inoue H, Nageshwar D. Reddy efficacy of peroral endoscopic myotomy (POEM) in the treatment of achalasia: a systematic review and meta-analysis. Surg Endosc. Nov;29(11):3030–3046.
  • Schlottmann F, Luckett DJ, Fine J, et al. Laparoscopic Heller Myotomy Versus Peroral Endoscopic Myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018 Mar;267(3):451–460.
  • Costantini A, Familiari P, Costantini M, et al. Poem versus laparoscopic Heller myotomy in the treatment of esophageal achalasia: a case-control study from two high volume centers using the propensity score. J Gastrointest Surg. 2020 Mar;24(3):505–515.
  • Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019 Dec 5 381(23):2219–2229.
  • Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019 Jul 9 322(2):134–144.
  • Shiwaku H, Sato H, Shimamura Y, et al. Risk factors and long-term course of gastroesophageal reflux disease after peroral endoscopic myotomy: a large-scale multicenter cohort study in Japan. Endoscopy. 2022;54(9):839–847 .
  • McKay SC, Dunst CM, Ahmed M, et al. POEM: clinical outcomes beyond 5 years. Surg Endosc. 2021 Oct;35(10):5709–5716.
  • Lois AW, Oelschlager BK, Wright AS, et al. Use and safety of Per-Oral Endoscopic Myotomy for achalasia in the US. JAMA Surg. 2022 Jun 1 157(6):490–497.
  • Youssef Y, Richards WO, Sharp K, et al. Relief of dysphagia after laparoscopic Heller myotomy improves long-term quality of life. J Gastrointest Surg. 2007;11(3):309–313.
  • Donahue PE, Horgan S, Liu KJ, et al. Floppy dor fundoplication after esophagocardiomyotomy for achalasia. Surgery. 2002;132(4):716–722. discussion 722-713.
  • Lynch KL, Pandolfino JE, Howden CW, et al. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–1825.
  • Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single Centre experience. Ann Surg. 2008;248(6):986–993.
  • Kumbhari V, Tieu A, Onimaru M, et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open. 2015;3(3):E195–E201.
  • Schuchert MJ, Luketich JD, Landreneau RJ, et al. Minimally invasive surgical treatment of sigmoidal esophagus in achalasia. J Gastrointest Surg. 2009;13(6):1029–1035. discussion 1035-1026.
  • Robert M, Poncet G, Mion F, et al. Results of laparoscopic Heller myotomy without anti-reflux procedure in achalasia. Monocentric prospective study of 106 cases. Surg Endosc. 2008;22(4):866–874.
  • Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249(1):45–57.
  • Gouda BP, Nelson T, Bhoyrul S. Revisional surgery after heller myotomy for treatment of achalasia: a comparative analysis focusing on operative approach. Indian J Surg. 2012;74(4):309–313.
  • Di Martino N, Monaco L, Izzo G, et al. The effect of esophageal myotomy and myectomy on the lower esophageal sphincter pressure profile: intraoperative computerized manometry study. Dis Esophagus. 2005;18(3):160–165.
  • Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg. 2004 Mar;239(3):364–370.
  • Wu PI, Szczesniak MM, Craig PI, et al. Novel intra-procedural distensibility measurement accurately predicts immediate outcome of pneumatic dilatation for idiopathic achalasia. Am J Gastroenterol. 2018 Feb;113(2):205–212.
  • Campagna RAJ, Carlson DA, Hungness ES, et al. Intraoperative assessment of esophageal motility using FLIP during myotomy for achalasia. Surg Endosc. 2020 Jun;34(6):2593–2600.
  • Holmstrom AL, Campagna RJ, Carlson DA, et al. Comparison of preoperative, intraoperative, and follow-up functional luminal imaging probe measurements in patients undergoing myotomy for achalasia. Gastrointest Endosc. 2021 Sep;94(3):509–514.
  • Kappelle WF, Bogte A, Siersema PD. Hydraulic dilation with a shape-measuring balloon in idiopathic achalasia: a feasibility study. Endoscopy. 2015;47(11):1028–1034.
  • Visaggi P, de Bortoli N, Barberio B, et al. Artificial intelligence in the diagnosis of upper gastrointestinal diseases. J Clin Gastroenterol. 2022 Jan 1 56(1):23–35.
  • Sinonquel P, Bisschops R. Striving for quality improvement: can artificial intelligence help? Best Pract Res Clin Gastroenterol. 2021 Jun-Aug;52-53:101722.
  • Tokat M, van Tilburg L, Koch AD, et al. Artificial intelligence in upper gastrointestinal endoscopy. Dig Dis. 2022;40(4):395–408.
  • Kröner PT, Engels MM, Glicksberg BS, et al. Artificial intelligence in gastroenterology: a state-of-the-art review. World J Gastroenterol. 2021 Oct 28 27(40):6794–6824.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.